TG Therapeutics, Inc. (TGTX) ownership: insiders 9% · institutions 71% · index and ETF funds 10% (13F 2026-06-30). Insider activity, 90 days: 0 sales, 0 open-market buys. SEC EDGAR first-party data.
| Holder | Shares | Market Value | % Outstanding | Reported |
|---|---|---|---|---|
| BlackRock | 22050045.00 | $1.21B | 14.4% | 2026-06-30 |
| Vanguard | 15326702.00 | $842.05M | 10.0% | 2026-06-30 |
| State Street | 7786471.00 | $427.79M | 5.1% | 2026-06-30 |
| Geode Capital Management | 3642216.00 | $200.14M | 2.4% | 2026-06-30 |
| D. E. Shaw | 3400808.00 | $186.84M | 2.2% | 2026-06-30 |
| CalSTRS | 9374083.00 | $170.62M | 6.1% | 2026-06-30 |
| Soleus Capital Management, L.P. | 2927895.00 | $160.86M | 1.9% | 2026-06-30 |
| Price T Rowe Associates Inc | 2767656.00 | $152.06M | 1.8% | 2026-06-30 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-08-06 | |
| Sell | null | 2026-08-06 | |
| Sell | null | 2026-08-06 | |
| Sell | null | 2026-06-11 | |
| Sell | null | 2026-06-11 | |
| Sell | null | 2026-06-11 | |
| Sell | null | 2026-06-11 | |
| Sell | null | 2026-06-11 |
Back to TGTX overview · TGTX earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.